SCHEMBL2440720

SCHEMBL2440720

O=[N+]([O-])CCc1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
TAAR1 Q96RJ0 2/20 0.46
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CNR1 P21554 1/20 0.42
MAPT P10636 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 1/20 0.41
HSP90AA1 P07900 1/20 0.41
XBP1 P17861 1/20 0.41
ALOX12 P18054 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAOB P27338 1/20 0.41
IDO1 P14902 2/20 0.40
PLAAT3 P53816 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17541809 0.89 TSHR (0.46) CYP1A2CYP2C19ALDH1A1CNR1TSHR
SCHEMBL11560785 0.88 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19TAAR1MEN1
SCHEMBL19396004 0.78 CA2 (0.48) ALDH1A1L3MBTL1TSHR
SCHEMBL188308 0.78 TSHR (0.64) CYP2C19ALDH1A1IDO1TSHR
SCHEMBL2441925 0.78 ACHE (0.46) CYP1A2TAAR1MEN1ALDH1A1KMT2A
SCHEMBL4543334 0.78 ESR1 (0.54) CYP2C19TAAR1ALDH1A1KMT2AL3MBTL1
SCHEMBL10618120 0.78 ALDH1A1 (0.40) CYP1A2CYP2C9CYP2C19MEN1ALDH1A1
SCHEMBL4087046 0.78 GFER (0.54) MEN1ALDH1A1KMT2AMAPTMAOB
SCHEMBL19396020 0.78 TAAR1 (0.46) TAAR1MEN1ALDH1A1KMT2AMAPT
SCHEMBL12708608 0.78 TSHR (0.48) CYP1A2CYP2C19ALDH1A1MAPTIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111763162-A Diamine compound containing sulfoxide group bridge chain, and synthetic method and application thereof 武汉依麦德新材料科技有限责任公司 2020-10-13 CN disclosed
US-20140228564-A1 PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-08-14 US disclosed
US-8680335-B2 Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-03-25 US disclosed
US-20110224429-A1 PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2011-09-15 US disclosed
US-6268514-B1 TREATING INDUSTRIAL MATERIALS WITH NITROETHANE COMPOUND FOR PROTECTING AGAINST ATTACK AND DESTRUCTION BY MICROORGANISMS BASF AKTIENGESELLSCHAFT (DE) 2001-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224429-A1 PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND AHR, CYP2S1, CYP1A1 CYP1A2 4/4885CYP2C9 12/4885CYP2C19 58/4885
US-20140228564-A1 PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND AHR, CYP2S1, CYP1A1 CYP1A2 4/4885CYP2C9 12/4885CYP2C19 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.